Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Paliperidone ER in Stable Symptomatic Schizophrenia
NCT01010776Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paliperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Started Feb 2008; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01010776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01010776.